Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2735

TR 365 Rat Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                    PENTAERYTHRITOL TETRANITRATE


NTP Experiment-Test: 05023-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/04/94
Route: DOSED FEED                                                                                                 Time: 00:40:07




       Facility:  TSI Mason Research

       Chemical CAS #:  78-11-5

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.62%        1.25%                                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Moribund                                          13           15           18                                                  
    Dead                                               3            2            1                                                  
    Natural Death                                      1                                                                            
  Survivors                                                                                                                         
    Terminal Sacrifice                                33           33           31                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (49)         (44)         (49)                                                
      Hyperkeratosis                                                             1 (2%)                                             
   Intestine Large, Colon                             (48)         (10)         (50)                                                
      Parasite                                         5 (10%)                   7 (14%)                                            
   Intestine Large, Rectum                            (46)         (10)         (48)                                                
      Parasite                                         1 (2%)                                                                       
   Intestine Small, Ileum                             (46)         (13)         (49)                                                
      Lymphoid Nodule, Hyperplasia                                  2 (15%)      1 (2%)                                             
   Intestine Small, Jejunum                           (47)         (10)         (49)                                                
      Lymphoid Nodule, Hyperplasia                                               1 (2%)                                             
   Liver                                              (50)         (50)         (50)                                                
      Angiectasis                                      1 (2%)       2 (4%)       3 (6%)                                             
      Basophilic Focus                                41 (82%)     41 (82%)     43 (86%)                                            
      Clear Cell Focus                                 1 (2%)       2 (4%)       1 (2%)                                             
      Congestion                                       1 (2%)                    1 (2%)                                             
      Developmental Malformation                       2 (4%)                    3 (6%)                                             
      Eosinophilic Focus                               1 (2%)       3 (6%)       1 (2%)                                             
      Fatty Change, Diffuse                            6 (12%)      5 (10%)      4 (8%)                                             
      Fatty Change, Focal                              4 (8%)       4 (8%)       8 (16%)                                            
      Focal Cellular Change                            2 (4%)                    3 (6%)                                             
      Hepatodiaphragmatic Nodule                       2 (4%)       7 (14%)      3 (6%)                                             
      Hyperplasia                                      1 (2%)       2 (4%)                                                          
      Inflammation, Chronic, Focal                     1 (2%)                                                                       
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
      Inflammation, Granulomatous                      1 (2%)                                                                       
      Mixed Cell Focus                                 3 (6%)       1 (2%)       3 (6%)                                             
      Necrosis                                         1 (2%)       2 (4%)       1 (2%)                                             
      Bile Duct, Hyperplasia                           4 (8%)       2 (4%)       2 (4%)                                             
   Mesentery                                          (3)          (4)          (4)                                                 
      Artery, Inflammation, Chronic Active                          1 (25%)                                                         
      Artery, Pigmentation                                          1 (25%)                                                         
      Artery, Thrombosis                                            1 (25%)                                                         
      Fat, Hemorrhage                                  1 (33%)                   1 (25%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.62%        1.25%                                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Fat, Necrosis                                    2 (67%)      2 (50%)      3 (75%)                                            
      Fat, Pigmentation                                             1 (25%)                                                         
   Pancreas                                           (50)         (17)         (49)                                                
      Acinus, Atrophy                                  1 (2%)                    1 (2%)                                             
      Artery, Inflammation, Chronic Active                          1 (6%)                                                          
   Pharynx                                            (1)                       (1)                                                 
      Palate, Epithelium, Hyperplasia                                            1 (100%)                                           
   Salivary Glands                                    (50)         (13)         (49)                                                
      Inflammation, Acute                                           1 (8%)                                                          
   Stomach, Forestomach                               (50)         (11)         (48)                                                
      Acanthosis                                       2 (4%)       1 (9%)       4 (8%)                                             
      Hyperkeratosis                                   2 (4%)       1 (9%)       7 (15%)                                            
      Inflammation, Chronic Active                                  2 (18%)                                                         
      Necrosis                                                      2 (18%)      1 (2%)                                             
   Stomach, Glandular                                 (50)         (11)         (50)                                                
      Hyperplasia                                                                4 (8%)                                             
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Mineralization                                   2 (4%)                    2 (4%)                                             
      Necrosis                                         1 (2%)       1 (9%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (10)         (50)                                                
      Cardiomyopathy                                  28 (56%)      3 (30%)     23 (46%)                                            
      Artery, Necrosis, Fibrinoid                      1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (49)         (12)         (49)                                                
      Degeneration                                     1 (2%)                                                                       
      Hyperplasia                                      1 (2%)                    2 (4%)                                             
      Necrosis                                                                   1 (2%)                                             
   Adrenal Gland, Medulla                             (49)         (12)         (49)                                                
      Hyperplasia                                      6 (12%)      1 (8%)       7 (14%)                                            
      Necrosis                                                                   1 (2%)                                             
   Pituitary Gland                                    (50)         (30)         (49)                                                
      Hyperplasia                                      2 (4%)                                                                       
      Hyperplasia, Focal                               1 (2%)                    1 (2%)                                             
      Pars Distalis, Angiectasis                      28 (56%)     18 (60%)     26 (53%)                                            
      Pars Distalis, Cyst                              2 (4%)       3 (10%)      2 (4%)                                             
      Pars Distalis, Cyst, Multiple                    1 (2%)                                                                       
      Pars Distalis, Hemorrhage                                                  1 (2%)                                             
      Pars Distalis, Hyperplasia                      15 (30%)      3 (10%)     16 (33%)                                            
      Pars Distalis, Pigmentation                                                2 (4%)                                             
      Pars Intermedia, Hyperplasia                                  2 (7%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.62%        1.25%                                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Nervosa, Cyst, Multiple                                               1 (2%)                                             
   Thyroid Gland                                      (50)         (48)         (50)                                                
      Necrosis                                                                   1 (2%)                                             
      C-Cell, Hyperplasia                              7 (14%)      9 (19%)      5 (10%)                                            
      Follicular Cell, Hyperplasia                     1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (39)         (12)         (41)                                                
      Dilatation                                                                 1 (2%)                                             
      Hyperplasia                                      3 (8%)       1 (8%)       2 (5%)                                             
      Inflammation, Acute                                           1 (8%)                                                          
      Inflammation, Chronic Active                     1 (3%)       2 (17%)      2 (5%)                                             
      Necrosis                                         7 (18%)      1 (8%)       3 (7%)                                             
   Ovary                                              (50)         (15)         (50)                                                
      Cyst                                             4 (8%)       4 (27%)      3 (6%)                                             
   Uterus                                             (50)         (48)         (50)                                                
      Necrosis                                                                   2 (4%)                                             
      Pigmentation                                                  1 (2%)                                                          
      Endometrium, Hyperplasia                                                   1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (50)         (17)         (49)                                                
      Mediastinal, Angiectasis                         1 (2%)       1 (6%)                                                          
      Mediastinal, Congestion                                                    1 (2%)                                             
      Mediastinal, Hemorrhage                                                    1 (2%)                                             
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                                1 (6%)                                                          
      Mediastinal, Pigmentation                        2 (4%)                    3 (6%)                                             
      Pancreatic, Infiltration Cellular, Histiocyte                 2 (12%)                                                         
      Pancreatic, Pigmentation                         1 (2%)                                                                       
      Renal, Angiectasis                                            1 (6%)       1 (2%)                                             
      Renal, Infiltration Cellular, Histiocyte                      1 (6%)                                                          
   Lymph Node, Mandibular                             (46)         (11)         (47)                                                
      Angiectasis                                      1 (2%)                                                                       
      Degeneration, Cystic                                          1 (9%)                                                          
      Infiltration Cellular, Plasma Cell                            1 (9%)       2 (4%)                                             
   Lymph Node, Mesenteric                             (49)         (12)         (48)                                                
      Angiectasis                                      1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.62%        1.25%                                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Congestion                                                                 2 (4%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Infiltration Cellular, Histiocyte                             1 (8%)                                                          
      Necrosis                                                                   1 (2%)                                             
   Spleen                                             (49)         (26)         (50)                                                
      Angiectasis                                                                1 (2%)                                             
      Depletion Lymphoid                               1 (2%)       1 (4%)                                                          
      Fibrosis                                         1 (2%)                                                                       
      Hematopoietic Cell Proliferation                33 (67%)     12 (46%)     41 (82%)                                            
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia, Reticulum Cell                      1 (2%)                                                                       
      Necrosis                                         1 (2%)       1 (4%)       1 (2%)                                             
      Pigmentation                                    33 (67%)     10 (38%)     38 (76%)                                            
   Thymus                                             (46)         (10)         (44)                                                
      Depletion Lymphoid                                                         1 (2%)                                             
      Epithelial Cell, Hyperplasia                     2 (4%)                    2 (5%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (46)         (34)         (48)                                                
      Galactocele                                     35 (76%)     15 (44%)     32 (67%)                                            
      Acinus, Hyperplasia                              1 (2%)       1 (3%)       3 (6%)                                             
   Skin                                               (49)         (15)         (50)                                                
      Acanthosis                                       1 (2%)                    1 (2%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Hyperkeratosis                                   2 (4%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (10)         (50)                                                
      Hemorrhage                                       1 (2%)                    1 (2%)                                             
      Hydrocephalus                                                 1 (10%)                                                         
      Mineralization                                                             1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.62%        1.25%                                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)                                                
      Congestion                                       4 (8%)      30 (60%)      2 (4%)                                             
      Edema                                            1 (2%)                    2 (4%)                                             
      Fibrosis                                                      1 (2%)                                                          
      Hemorrhage                                       6 (12%)      3 (6%)       5 (10%)                                            
      Infiltration Cellular, Histiocyte                5 (10%)                   7 (14%)                                            
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Mineralization                                                             1 (2%)                                             
      Necrosis                                                                   1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 1 (2%)       2 (4%)                                                          
      Goblet Cell, Hypertrophy                                                   1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                (2)          (2)                                                              
      Acanthosis                                       1 (50%)                                                                      
      Hyperkeratosis                                   2 (100%)                                                                     
   Eye                                                (6)          (7)          (5)                                                 
      Cornea, Inflammation, Chronic Active                                       1 (20%)                                            
      Lens, Cataract                                                1 (14%)                                                         
      Retina, Atrophy                                               2 (29%)                                                         
   Harderian Gland                                    (3)          (3)          (3)                                                 
      Abscess                                                                    1 (33%)                                            
      Pigmentation                                                               1 (33%)                                            
   Zymbal's Gland                                     (36)         (37)         (35)                                                
      Cyst                                                          1 (3%)       1 (3%)                                             
      Hyperplasia                                      1 (3%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)                                                
      Fibrosis                                                                   1 (2%)                                             
      Nephropathy                                     46 (92%)     39 (78%)     49 (98%)                                            
      Cortex, Mineralization                           4 (8%)       1 (2%)       7 (14%)                                            
      Cortex, Necrosis                                              1 (2%)                                                          
      Papilla, Mineralization                                       1 (2%)       4 (8%)                                             
      Pelvis, Mineralization                                        1 (2%)       1 (2%)                                             
      Renal Tubule, Hyperplasia                                     1 (2%)       1 (2%)                                             
      Renal Tubule, Pigmentation                       1 (2%)       1 (2%)       2 (4%)                                             
      Transitional Epithelium, Hyperplasia                          2 (4%)                                                          
   Urinary Bladder                                    (49)         (10)         (49)                                                
      Hemorrhage                                                    1 (10%)                                                         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.62%        1.25%                                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Inflammation, Chronic Active                                  1 (10%)                                                         
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Moribund                                          20           16           16                                                  
    Dead                                               8            5            5                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                21           28           29                                                  
    Moribund                                                        1                                                               
    Terminal Sacrifice                                 1                                                                            
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (47)         (10)         (48)                                                
      Parasite                                         6 (13%)      2 (20%)     14 (29%)                                            
   Intestine Large, Rectum                            (46)         (9)          (48)                                                
      Parasite                                         1 (2%)                    2 (4%)                                             
   Intestine Small, Ileum                             (47)         (7)          (47)                                                
      Lymphoid Tissue, Hyperplasia                                               1 (2%)                                             
   Liver                                              (49)         (50)         (50)                                                
      Angiectasis                                      5 (10%)      7 (14%)      8 (16%)                                            
      Basophilic Focus                                25 (51%)     19 (38%)     25 (50%)                                            
      Clear Cell Focus                                 2 (4%)       4 (8%)       3 (6%)                                             
      Congestion                                       1 (2%)                    1 (2%)                                             
      Degeneration, Cystic                             3 (6%)       6 (12%)      6 (12%)                                            
      Developmental Malformation                                    2 (4%)       1 (2%)                                             
      Eosinophilic Focus                               1 (2%)       1 (2%)                                                          
      Fatty Change, Diffuse                            3 (6%)       1 (2%)       1 (2%)                                             
      Fatty Change, Focal                              7 (14%)      4 (8%)       5 (10%)                                            
      Focal Cellular Change                            2 (4%)                    8 (16%)                                            
      Hemorrhage                                                                 2 (4%)                                             
      Hepatodiaphragmatic Nodule                       4 (8%)       1 (2%)                                                          
      Hyperplasia                                      3 (6%)       2 (4%)                                                          
      Hyperplasia, Focal                               1 (2%)       1 (2%)       5 (10%)                                            
      Hyperplasia, Multifocal                                       1 (2%)       1 (2%)                                             
      Inflammation                                                               1 (2%)                                             
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Mixed Cell Focus                                 4 (8%)       9 (18%)      3 (6%)                                             
      Necrosis                                         3 (6%)       1 (2%)       4 (8%)                                             
      Pigmentation                                                  1 (2%)                                                          
      Thrombosis                                                    2 (4%)                                                          
      Vacuolization Cytoplasmic                        1 (2%)                                                                       
      Bile Duct, Hyperplasia                          39 (80%)     31 (62%)     35 (70%)                                            
      Oval Cell, Hyperplasia                           1 (2%)                                                                       
   Mesentery                                          (5)          (2)          (9)                                                 
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hemorrhage                                                                 1 (11%)                                            
      Fat, Mineralization                              2 (40%)                   1 (11%)                                            
      Fat, Necrosis                                    2 (40%)      1 (50%)      6 (67%)                                            
      Fat, Pigmentation                                                          3 (33%)                                            
   Pancreas                                           (49)         (49)         (48)                                                
      Fibrosis                                                                   1 (2%)                                             
      Acinus, Atrophy                                  1 (2%)       2 (4%)                                                          
      Acinus, Hyperplasia                              3 (6%)       6 (12%)      2 (4%)                                             
      Acinus, Hyperplasia, Focal                                    1 (2%)       1 (2%)                                             
      Artery, Hemorrhage                                            1 (2%)                                                          
      Artery, Inflammation, Chronic Active                          2 (4%)                                                          
      Artery, Mineralization                           1 (2%)                                                                       
      Artery, Necrosis, Fibrinoid                      4 (8%)       2 (4%)       1 (2%)                                             
      Duct, Hyperplasia                                                          1 (2%)                                             
   Pharynx                                                                      (1)                                                 
      Palate, Epithelium, Hyperplasia                                            1 (100%)                                           
   Salivary Glands                                    (48)         (13)         (49)                                                
      Inflammation, Chronic Active                                  1 (8%)                                                          
   Stomach, Forestomach                               (49)         (14)         (48)                                                
      Acanthosis                                       3 (6%)       4 (29%)      2 (4%)                                             
      Edema                                            1 (2%)                    1 (2%)                                             
      Fibrosis                                         1 (2%)                                                                       
      Hyperkeratosis                                   4 (8%)                    7 (15%)                                            
      Hyperplasia, Basal Cell                                                    1 (2%)                                             
      Inflammation, Chronic                                         2 (14%)                                                         
      Inflammation, Chronic Active                     2 (4%)                    1 (2%)                                             
      Necrosis                                         2 (4%)                                                                       
      Ulcer                                                         2 (14%)                                                         
   Stomach, Glandular                                 (48)         (15)         (47)                                                
      Degeneration                                                               1 (2%)                                             
      Erosion                                                       3 (20%)                                                         
      Hyperplasia                                                                3 (6%)                                             
      Infiltration Cellular, Lymphocyte                             2 (13%)      2 (4%)                                             
      Inflammation, Chronic                                         2 (13%)                                                         
      Mineralization                                   1 (2%)                    2 (4%)                                             
      Necrosis                                         1 (2%)       1 (7%)       1 (2%)                                             
      Pigmentation                                                               1 (2%)                                             
   Tongue                                             (2)          (1)                                                              
      Hyperkeratosis                                   1 (50%)                                                                      
   Tooth                                              (1)                                                                           
      Gingiva, Inflammation, Chronic                   1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (49)         (15)         (50)                                                
      Cardiomyopathy                                  37 (76%)     13 (87%)     47 (94%)                                            
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mineralization                                                             1 (2%)                                             
      Thrombosis                                                    3 (20%)                                                         
      Artery, Mineralization                           2 (4%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (49)         (18)         (48)                                                
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia                                      1 (2%)                    2 (4%)                                             
      Hypertrophy                                                   1 (6%)                                                          
      Vacuolization Cytoplasmic, Diffuse                                         1 (2%)                                             
   Adrenal Gland, Medulla                             (49)         (18)         (48)                                                
      Hyperplasia                                     25 (51%)      5 (28%)     21 (44%)                                            
   Islets, Pancreatic                                 (49)         (45)         (47)                                                
      Hyperplasia                                                   2 (4%)                                                          
      Hyperplasia, Focal                                            1 (2%)                                                          
   Parathyroid Gland                                  (40)         (9)          (42)                                                
      Hyperplasia                                      2 (5%)                                                                       
   Pituitary Gland                                    (49)         (20)         (50)                                                
      Pars Distalis, Angiectasis                      12 (24%)     11 (55%)      6 (12%)                                            
      Pars Distalis, Cyst                              2 (4%)                                                                       
      Pars Distalis, Hyperplasia                      10 (20%)      3 (15%)     21 (42%)                                            
      Pars Distalis, Hyperplasia, Focal                1 (2%)                                                                       
      Pars Intermedia, Hyperplasia                     1 (2%)       1 (5%)       3 (6%)                                             
   Thyroid Gland                                      (49)         (15)         (50)                                                
      C-Cell, Hyperplasia                              4 (8%)                    6 (12%)                                            
      Follicle, Cyst                                                             1 (2%)                                             
      Follicular Cell, Hyperplasia                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                                                   (1)                                                 
      Necrosis                                                                   1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (48)         (13)         (50)                                                
      Mineralization                                   4 (8%)                                                                       
   Preputial Gland                                    (46)         (22)         (50)                                                
      Dilatation                                       1 (2%)                    1 (2%)                                             
      Hyperplasia                                                                1 (2%)                                             
      Inflammation, Acute                                           2 (9%)                                                          
      Inflammation, Chronic Active                     2 (4%)                    3 (6%)                                             
      Necrosis                                         7 (15%)      1 (5%)       7 (14%)                                            
   Prostate                                           (48)         (13)         (50)                                                
      Inflammation                                                               1 (2%)                                             
      Inflammation, Chronic Active                    12 (25%)      3 (23%)      9 (18%)                                            
      Mineralization                                                             1 (2%)                                             
      Necrosis                                                                   1 (2%)                                             
      Pigmentation                                     1 (2%)                                                                       
      Epithelium, Hyperplasia                          1 (2%)                    4 (8%)                                             
   Seminal Vesicle                                    (49)         (23)         (50)                                                
      Atrophy                                          3 (6%)                                                                       
   Testes                                             (49)         (50)         (50)                                                
      Interstitial Cell, Hyperplasia                  28 (57%)     23 (46%)     25 (50%)                                            
      Seminiferous Tubule, Atrophy                    43 (88%)     32 (64%)     44 (88%)                                            
      Seminiferous Tubule, Mineralization              4 (8%)                    2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (48)         (10)         (50)                                                
      Hyperplasia, Reticulum Cell                                                1 (2%)                                             
   Lymph Node                                         (48)         (30)         (50)                                                
      Axillary, Infiltration Cellular, Plasma Cell                  1 (3%)                                                          
      Inguinal, Infiltration Cellular, Plasma Cell                  1 (3%)                                                          
      Lumbar, Congestion                               1 (2%)                                                                       
      Lumbar, Infiltration Cellular, Plasma Cell       1 (2%)                                                                       
      Lumbar, Infiltration Cellular, Histiocyte                     1 (3%)                                                          
      Lumbar, Pigmentation                                                       1 (2%)                                             
      Mediastinal, Angiectasis                         2 (4%)       2 (7%)                                                          
      Mediastinal, Congestion                                                    1 (2%)                                             
      Mediastinal, Depletion Lymphoid                                            1 (2%)                                             
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                                1 (3%)                                                          
      Mediastinal, Pigmentation                        3 (6%)       1 (3%)       2 (4%)                                             
      Pancreatic, Angiectasis                                       1 (3%)                                                          
      Pancreatic, Cyst                                                           1 (2%)                                             
      Pancreatic, Depletion Lymphoid                                             1 (2%)                                             
      Pancreatic, Hematocyst                                                     1 (2%)                                             
      Pancreatic, Hemorrhage                                                     1 (2%)                                             
      Pancreatic, Infiltration Cellular, Plasma                                                                                     
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
          Cell                                         1 (2%)                    1 (2%)                                             
      Pancreatic, Infiltration Cellular, Histiocyte                 3 (10%)      1 (2%)                                             
      Renal, Infiltration Cellular, Histiocyte                      2 (7%)       1 (2%)                                             
      Renal, Pigmentation                              1 (2%)                    2 (4%)                                             
   Lymph Node, Mandibular                             (46)         (20)         (49)                                                
      Angiectasis                                                   1 (5%)                                                          
      Cyst                                             4 (9%)                    2 (4%)                                             
      Degeneration, Cystic                                          1 (5%)       1 (2%)                                             
      Erythrophagocytosis                              1 (2%)                                                                       
      Hemorrhage                                       2 (4%)                                                                       
      Infiltration Cellular, Plasma Cell                            2 (10%)                                                         
   Lymph Node, Mesenteric                             (47)         (15)         (48)                                                
      Angiectasis                                                   1 (7%)       1 (2%)                                             
      Degeneration, Cystic                             1 (2%)                    2 (4%)                                             
      Hemorrhage                                       1 (2%)       1 (7%)       1 (2%)                                             
      Infiltration Cellular, Plasma Cell               1 (2%)       1 (7%)                                                          
      Infiltration Cellular, Histiocyte                                          2 (4%)                                             
      Necrosis                                                                   1 (2%)                                             
   Spleen                                             (48)         (36)         (50)                                                
      Atrophy                                                                    1 (2%)                                             
      Congestion                                       2 (4%)                                                                       
      Depletion Lymphoid                               1 (2%)       1 (3%)       2 (4%)                                             
      Fibrosis                                         1 (2%)       2 (6%)       2 (4%)                                             
      Hematopoietic Cell Proliferation                26 (54%)     14 (39%)     28 (56%)                                            
      Hemorrhage                                                    4 (11%)                                                         
      Mineralization                                                1 (3%)                                                          
      Necrosis                                         1 (2%)       1 (3%)                                                          
      Pigmentation                                     6 (13%)      2 (6%)      15 (30%)                                            
      Thrombosis                                                    1 (3%)                                                          
   Thymus                                             (36)         (17)         (45)                                                
      Depletion Lymphoid                               3 (8%)       1 (6%)       3 (7%)                                             
      Epithelial Cell, Hyperplasia                     1 (3%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (37)         (9)          (38)                                                
      Galactocele                                      4 (11%)                   6 (16%)                                            
      Acinus, Hyperplasia                              1 (3%)                    1 (3%)                                             
   Skin                                               (48)         (18)         (50)                                                
      Acanthosis                                       3 (6%)       4 (22%)      4 (8%)                                             
      Cyst Epithelial Inclusion                                     2 (11%)                                                         
      Erosion                                                                    1 (2%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Hyperkeratosis                                   4 (8%)       4 (22%)      5 (10%)                                            
      Inflammation, Chronic Active                                               1 (2%)                                             
      Necrosis                                         2 (4%)                    2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (49)         (10)         (50)                                                
      Tarsal, Hyperostosis                                                       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (49)         (48)         (50)                                                
      Hemorrhage                                       3 (6%)       1 (2%)       2 (4%)                                             
   Spinal Cord                                                     (1)                                                              
      Hemorrhage                                                    1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (49)         (28)         (50)                                                
      Atelectasis                                      1 (2%)       1 (4%)                                                          
      Congestion                                      10 (20%)     10 (36%)     11 (22%)                                            
      Edema                                            3 (6%)       1 (4%)       2 (4%)                                             
      Embolus Tumor                                    1 (2%)                                                                       
      Fibrosis                                         1 (2%)                                                                       
      Hemorrhage                                       6 (12%)      2 (7%)       6 (12%)                                            
      Infiltration Cellular, Histiocyte                4 (8%)       1 (4%)      11 (22%)                                            
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic Active                     1 (2%)                    5 (10%)                                            
      Alveolar Epithelium, Hyperplasia                 2 (4%)                    1 (2%)                                             
   Nose                                               (47)         (10)         (50)                                                
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Acute                              2 (4%)                    8 (16%)                                            
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
      Metaplasia, Osseous                                                        1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (5)          (9)          (6)                                                 
      Cornea, Inflammation, Acute                      1 (20%)                                                                      
      Lens, Cataract                                   1 (20%)      3 (33%)      1 (17%)                                            
   Zymbal's Gland                                     (49)         (45)         (41)                                                
      Cyst                                             6 (12%)      1 (2%)                                                          
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Granulomatous                      1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05023-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                    PENTAERYTHRITOL TETRANITRATE                               Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 00:40:07  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      2.5%         5.0%                                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (50)         (50)                                                
      Angiectasis                                                   1 (2%)                                                          
      Cyst                                             4 (8%)       1 (2%)       1 (2%)                                             
      Fibrosis                                                                   1 (2%)                                             
      Hydronephrosis                                                             2 (4%)                                             
      Necrosis                                                      1 (2%)                                                          
      Nephropathy                                     49 (100%)    49 (98%)     49 (98%)                                            
      Capsule, Fibrosis                                                          1 (2%)                                             
      Cortex, Mineralization                           5 (10%)                   7 (14%)                                            
      Papilla, Mineralization                          4 (8%)       1 (2%)       9 (18%)                                            
      Renal Tubule, Dilatation                                                   1 (2%)                                             
      Renal Tubule, Hyperplasia                                     3 (6%)                                                          
      Renal Tubule, Necrosis                           1 (2%)                    1 (2%)                                             
      Renal Tubule, Pigmentation                       3 (6%)       1 (2%)       5 (10%)                                            
      Transitional Epithelium, Hyperplasia             2 (4%)       8 (16%)      3 (6%)                                             
   Urinary Bladder                                    (46)         (10)         (48)                                                
      Calculus Gross Observation                                    1 (10%)      1 (2%)                                             
      Calculus Micro Observation Only                  1 (2%)       2 (20%)      1 (2%)                                             
      Fibrosis                                                                   1 (2%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Chronic Active                                               1 (2%)                                             
      Artery, Necrosis, Fibrinoid                      1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 89453-89453/89453


--multipart-boundary--